Skip to content

    GLOBUS MEDICAL (GMED) stock price & financials

    View GMED earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+34.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $625.71M
    $657.29M
    $598.12M
    $745.34M
    $769.05M
    +22.9%
    $826.42M
    +25.7%
    $759.85M
    +27.0%
    $789.61M
    +5.9%
    Strengthening
    Operating Profit
    $48.10M
    $60.27M
    $97.00M
    $76.11M
    $137.36M
    +185.6%
    $169.34M
    +181.0%
    $150.39M
    +55.0%
    $182.43M
    +139.7%
    Strengthening
    Net Profit
    $51.84M
    $26.50M
    $75.46M
    $202.85M
    $118.97M
    +129.5%
    $140.59M
    +430.4%
    $124.30M
    +64.7%
    $151.57M
    -25.3%
    Strengthening
    EPS
    $0.38
    $0.55
    $1.50
    $0.88
    +131.6%
    $0.92
    +67.3%
    $1.12
    -25.3%
    Strengthening
    Other Income
    $8.93M
    -$35.61M
    $6.66M
    $112.06M
    $6.63M
    -25.8%
    -$107.0K
    +99.7%
    $6.69M
    +0.3%
    $7.38M
    -93.4%
    Stable
    Interest
    Depreciation
    Profit before Tax
    $57.03M
    $24.67M
    $103.67M
    $188.17M
    $143.99M
    +152.5%
    $169.23M
    +586.1%
    $157.07M
    +51.5%
    $189.82M
    +0.9%
    Strengthening
    MarginsOPM
    7.7%
    9.2%
    16.2%
    10.2%
    17.9%
    +132.2%
    20.5%
    +123.4%
    19.8%
    +22.0%
    23.1%
    +126.2%
    Strengthening
    Tax
    9.1%
    -7.5%
    27.2%
    -7.8%
    17.4%
    +90.8%
    16.9%
    20.9%
    -23.3%
    20.1%
    Weakening
    ReturnsROIC
    3.6%
    1.8%
    5.2%
    14.1%
    8.3%
    +129.5%
    9.8%
    +430.4%
    8.6%
    +64.7%
    10.5%
    -25.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$139.65M$195.47M$239.40M$193.07M$150.47M$467.29M$784.44M$526.16M$507.75M
    Short-Term Investments$187.34M$250.38M$295.59M$50.50M$105.62M$31.09M$87.40M
    Total Current Assets$630.68M$687.47M$821.76M$864.52M$983.34M$1.92B$2.18B$2.13B$2.22B
    Net PP&E$171.87M$202.32M$221.62M$226.09M$249.72M$646.86M$611.56M$628.24M$592.68M
    Goodwill$123.73M$128.78M$156.72M$179.71M$197.47M$1.43B$1.43B$1.44B$1.44B
    Intangibles$87.32M$78.81M$86.95M$68.66M$63.57M$924.60M$795.12M$745.06M$692.62M
    Total Assets$1.30B$1.53B$1.68B$1.96B$2.08B$5.09B$5.25B$5.30B$5.49B
    LiabilitiesTotal Current Liabilities$96.12M$111.40M$120.79M$140.16M$159.20M$392.35M$855.91M$498.50M$479.35M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$1.14M$2.94M$2.94M$3.48M$91.04M$83.59M$103.92M$96.81M
    Total Liabilities$115.15M$129.63M$173.19M$215.88M$229.75M$1.09B$1.07B$729.51M$719.65M
    EquityCommon Stock & APIC
    Retained Earnings$892.72M$1.05B$1.05B$1.19B$1.24B$1.14B$1.15B$1.39B$1.53B
    Total Equity$1.19B$1.40B$1.51B$1.74B$1.85B$4.00B$4.18B$4.57B$4.77B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$181.64M$171.97M$198.79M$276.27M$178.47M$243.50M$520.64M$753.45M$910.39M
    Cash from Investing-$193.03M-$140.28M-$117.32M-$375.94M-$110.36M$302.97M-$176.05M-$355.01M-$499.01M
    Cash from Financing$32.57M$24.44M-$38.66M$54.15M-$109.96M-$231.82M-$27.70M-$679.16M-$135.13M
    SummaryCapital Expenditure-$59.70M-$70.75M-$63.66M-$56.90M-$74.05M-$78.27M-$115.43M-$164.68M-$154.80M
    Free Cash Flow$121.95M$101.22M$135.13M$219.38M$104.42M$165.22M$405.21M$588.77M$755.59M
    FCF Margin17.1%12.9%17.1%22.9%10.2%10.5%16.1%20.0%24.0%

    Ratios